Literature DB >> 18802965

Generation of a conditional null allele for Cftr in mice.

Craig A Hodges1, Calvin U Cotton, Mark R Palmert, Mitchell L Drumm.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) gene encodes a cAMP-regulated chloride channel that is important in controlling the exchange of fluid and electrolytes across epithelial cells. Mutation of CFTR can lead to cystic fibrosis (CF), the most common lethal genetic disease in Caucasians. CF is a systemic illness with multiple organ systems affected including pulmonary, gastrointestinal, pancreatic, immune, endocrine, and reproductive systems. To understand the role of CFTR in the various tissues in which it is expressed, we generated a murine conditional null allele of Cftr (Cftr(fl10)) in which loxP sites were inserted around exon 10 of the Cftr gene. The Cftr(fl10) allele was validated by generating constitutive Cftr null (Cftr(Delta10)) mice using the protamine-cre system. The Cftr(Delta10/Delta10) mice displayed almost identical phenotypes to previously published CF mouse models, including poor growth, decreased survival, intestinal obstruction, and loss of Cftr function as assessed by electrophysiology measurements on gut and nasal epithelium. Mice containing the conditional null Cftr allele will be useful in future studies to understand the role of Cftr in specific tissues and developmental time points and lead to a better understanding of CF disease. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802965      PMCID: PMC2711445          DOI: 10.1002/dvg.20433

Source DB:  PubMed          Journal:  Genesis        ISSN: 1526-954X            Impact factor:   2.487


  35 in total

1.  Examining basal chloride transport using the nasal potential difference response in a murine model.

Authors:  K G Brady; T J Kelley; M L Drumm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

2.  Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin.

Authors:  K Yoshimura; H Nakamura; B C Trapnell; C S Chu; W Dalemans; A Pavirani; J P Lecocq; R G Crystal
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator.

Authors:  A E Trezise; M Buchwald
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

4.  CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons.

Authors:  R T Weyler; K A Yurko-Mauro; R Rubenstein; W J Kollen; W Reenstra; S M Altschuler; M Egan; A E Mulberg
Journal:  Am J Physiol       Date:  1999-09

5.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

Review 6.  The spectrum of cystic fibrosis mutations.

Authors:  L C Tsui
Journal:  Trends Genet       Date:  1992-11       Impact factor: 11.639

7.  Cardiac expression of the cystic fibrosis transmembrane conductance regulator involves novel exon 1 usage to produce a unique amino-terminal protein.

Authors:  Wayne L Davies; Jamie I Vandenberg; Rana A Sayeed; Ann E O Trezise
Journal:  J Biol Chem       Date:  2004-01-30       Impact factor: 5.157

8.  Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation.

Authors:  Renaud Robert; Vincent Thoreau; Caroline Norez; Anne Cantereau; Alain Kitzis; Yvette Mettey; Christian Rogier; Frédéric Becq
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

9.  A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.

Authors:  Tudor C Badea; Yanshu Wang; Jeremy Nathans
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

10.  Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine.

Authors:  Blair B Madison; Laura Dunbar; Xiaotan T Qiao; Katherine Braunstein; Evan Braunstein; Deborah L Gumucio
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  29 in total

1.  Lack of cystic fibrosis transmembrane conductance regulator in CD3+ lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses.

Authors:  Christian Mueller; Sofia A Braag; Allison Keeler; Craig Hodges; Mitchell Drumm; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

2.  Parasympathetic innervation regulates tubulogenesis in the developing salivary gland.

Authors:  Pavel I Nedvetsky; Elaine Emmerson; Jennifer K Finley; Andreas Ettinger; Noel Cruz-Pacheco; Jan Prochazka; Candace L Haddox; Emily Northrup; Craig Hodges; Keith E Mostov; Matthew P Hoffman; Sarah M Knox
Journal:  Dev Cell       Date:  2014-08-25       Impact factor: 12.270

3.  CFTR is a tumor suppressor gene in murine and human intestinal cancer.

Authors:  B L N Than; J F Linnekamp; T K Starr; D A Largaespada; A Rod; Y Zhang; V Bruner; J Abrahante; A Schumann; T Luczak; A Niemczyk; M G O'Sullivan; J P Medema; R J A Fijneman; G A Meijer; E Van den Broek; C A Hodges; P M Scott; L Vermeulen; R T Cormier
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium.

Authors:  Craig A Hodges; Brian R Grady; Kirtishri Mishra; Calvin U Cotton; Mitchell L Drumm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-09       Impact factor: 4.052

5.  Impaired Renal HCO3 - Excretion in Cystic Fibrosis.

Authors:  Peder Berg; Samuel L Svendsen; Mads V Sorensen; Casper K Larsen; Jesper Frank Andersen; Søren Jensen-Fangel; Majbritt Jeppesen; Rainer Schreiber; Ines Cabrita; Karl Kunzelmann; Jens Leipziger
Journal:  J Am Soc Nephrol       Date:  2020-07-23       Impact factor: 10.121

Review 6.  New animal models of cystic fibrosis: what are they teaching us?

Authors:  Nicholas W Keiser; John F Engelhardt
Journal:  Curr Opin Pulm Med       Date:  2011-11       Impact factor: 3.155

7.  Cystic fibrosis-related diabetes is caused by islet loss and inflammation.

Authors:  Nathaniel J Hart; Radhika Aramandla; Gregory Poffenberger; Cody Fayolle; Ariel H Thames; Austin Bautista; Aliya F Spigelman; Jenny Aurielle B Babon; Megan E DeNicola; Prasanna K Dadi; William S Bush; Appakalai N Balamurugan; Marcela Brissova; Chunhua Dai; Nripesh Prasad; Rita Bottino; David A Jacobson; Mitchell L Drumm; Sally C Kent; Patrick E MacDonald; Alvin C Powers
Journal:  JCI Insight       Date:  2018-04-19

8.  The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.

Authors:  Kai Jiang; Sen Jiao; Megan Vitko; Rebecca Darrah; Chris A Flask; Craig A Hodges; Xin Yu
Journal:  J Cyst Fibros       Date:  2015-06-25       Impact factor: 5.482

Review 9.  Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology.

Authors:  Alicia K Olivier; Katherine N Gibson-Corley; David K Meyerholz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

10.  Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model.

Authors:  Manshu Tang; Anwer Siddiqi; Benjamin Witt; Tatiana Yuzyuk; Britt Johnson; Nisa Fraser; Wyman Chen; Rafael Rascon; Xue Yin; Harish Goli; Olaf A Bodamer; Kent Lai
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.